Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

ClinicalTrials.gov ID: NCT06899217

Public ClinicalTrials.gov record NCT06899217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 10:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help to decrease nausea severity associated with idiopathic gastroparesis severity in adult subjects. The main questions it aims to answer are: * To evaluate the efficacy of CIN-102 on symptoms of gastroparesis when given to patients with idiopathic gastroparesis compared to a placebo * To evaluate the safety of CIN-102 when given to patients with idiopathic gastroparesis compared to a placebo Participants will go through the following schedule: * Pre-screening (1 visit) * Screening \& Lead-In (1-2 visits) * Will complete a Gastric Emptying Breath Test (GEBT) * Will complete daily diary and other Patient Reported Outcomes (PROs) as described in the protocol to assess eligibility for continued study participation. * Lead-In Period (1 visit) * 12-week treatment period (7 visits) * Study drug taken twice daily by mouth * Will complete daily diaries and other PROs as described in protocol * 1 week follow-up (1 visit) Researchers will compare the effects of the following treatments: * 15 mg CIN-102, taken orally BID for 12 weeks * 10 mg CIN-102, taken orally BID for 12 weeks * Placebo for CIN-102, taken orally BID for 12 weeks

Study identification

NCT ID
NCT06899217
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
CinDome Pharma, Inc.
Industry
Enrollment
416 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 29, 2025 (Actual)
Primary completion
May 7, 2026 (Actual)
Completion
May 7, 2026 (Actual)
Last update posted
Jul 13, 2026

2025 – 2026

United States locations

U.S. sites
85
U.S. states
35
U.S. cities
81
Facility City State ZIP Site status
Gastro Health - Birmingham Birmingham Alabama 35235 —
G & L Research, LLC Foley Alabama 36535 —
The Center for Clinical Trials Saraland Alabama 36571 —
Del Sol Research Management, LLC Tucson Arizona 85715 —
Applied Research Center of Arkansas, Inc Little Rock Arkansas 72205 —
Preferred Research Partners, Inc. Little Rock Arkansas 72211 —
Hope Clinical Research LLC Canoga Park California 91303 —
Erick H. Alayo Medical Corporation Chula Vista California 91910 —
Flourish Research - Los Angeles (Covina) Covina California 91723 —
Gastro Care Institute Lancaster California 93534 —
Downtown L.A. Research Center, Inc. Los Angeles California 90017 —
Acclaim Clinical Research San Diego California 92120 —
Focus Clinical Research - West Hills West Hills California 91307 —
University of Colorado Anschutz Aurora Colorado 80045 —
Rocky Mountain Gastroenterology (RMG) Lakewood Colorado 80228 —
Paradigm Research - Wheatridge Wheat Ridge Colorado 80033 —
Connecticut Clinical Research Institute, LLC Bristol Connecticut 06010 —
American Family Research Group Cape Coral Florida 33909 —
USA and International Research Inc. Doral Florida 33126 —
Unique Clinical Trials Doral Florida 33172 —
Advanced Medical Research Group Hollywood Florida 33021 —
Nature Coast Clinical Research Inverness Florida 34452 —
ENCORE Borland Groover Clinical Research Jacksonville Florida 32256 —
Allied Biomedical Research Institute, Inc. Miami Florida 33155 —
Advanced Research Institute Inc New Port Richey Florida 34653 —
Sensible Healthcare, LLC Ocoee Florida 34761 —
GCP Research St. Petersburg Florida 33705 —
Summit Clinical Research, LLC Athens Georgia 30607 —
DelRicht Clinical Research - Atlanta Atlanta Georgia 30329 —
Gastrointestinal Specialists of Georgia PC Marietta Georgia 30060 —
Treasure Valley Medical Research Boise Idaho 83706 —
GI Alliance - Gurnee Gurnee Illinois 60031 —
Carle Clinic - Urbana Main Urbana Illinois 61801 —
Integrated Clinical Trial Services, Inc West Des Moines Iowa 50265 —
Kansas Medical Clinic, P.A. Topeka Kansas 66606 —
University of Louisville Louisville Kentucky 40202 —
Tandem Clinical Research Marrero Louisiana 70072 —
Delta Research Partners of West Monroe, LLC Monroe Louisiana 71201 —
NOLA Research Works New Orleans Louisiana 70125 —
Portland Gastroenterology Associates Portland Maine 04101 —
Capital Digestive Care - Chevy Chase Clinical Research Chevy Chase Maryland 20815 —
Sanmora Bespoke: Parkway Medical Association Glen Burnie Maryland 21061 —
Gastro Health - Framingham Framingham Massachusetts 01702 —
Aa Mrc, Llc Flint Michigan 48504 —
Huron Gastroenterology Ypsilanti Michigan 48197 —
Gastrointestinal Associates and Endoscopy Center, PA - Flowood Flowood Mississippi 39232 —
KAD Clinical Research, LLC St Louis Missouri 63123 —
St. Charles Clinical Research Weldon Spring Missouri 63304 —
Quality Clinical Research, Inc Omaha Nebraska 68114 —
Excel Clinical Research Las Vegas Nevada 89109 —
Digestive Disease Specialists Las Vegas Nevada 89128 —
Advanced Research Institute - Reno Reno Nevada 89511 —
Southwest Gastroenterology Associates Albuquerque New Mexico 87109 —
NY Scientific Brooklyn New York 11235 —
Westchester Putnam Gastro Carmel New York 10512 —
Atrium Health - Center for Gastroenterology and Hepatology MMP Charlotte North Carolina 28204 —
Cross Creek Medical Clinic, PA Fayetteville North Carolina 28304 —
Carolina Digestive Diseases & Endoscopy Center Greenville North Carolina 27834 —
Peters Medical Research High Point North Carolina 27260 —
Hometown Urgent Care and Research (Cincinnati) Cincinnati Ohio 45150 —
Urgent Care Specialists, LLC DBA Hometown Urgent Care and Occupational Health - Columbus Columbus Ohio 43228 —
Hometown Urgent Care and Research - Huber Heights Huber Heights Ohio 45424 —
Gastro Intestinal Research Institute of Northern Ohio, LLC Westlake Ohio 44145 —
Options Health Research Tulsa Oklahoma 74104 —
Advanced Research Institute - Portland Portland Oregon 97223 —
Susquehanna Research Group, LLC Harrisburg Pennsylvania 17110 —
Temple University Hospital Philadelphia Pennsylvania 19140 —
Frontier Clinical Research, LLC - Smithfield Smithfield Pennsylvania 15478 —
PPCP Division of Gastroenterology Summerville South Carolina 29486 —
Galen Medical Group Hixson Tennessee 37343 —
Digestive Health - UT Health Austin Austin Texas 78712 —
Zenos Clinical Research Dallas Texas 75230 —
EPIC Medical Research DeSoto Texas 75115 —
Amir A Hassan, MD, PA Houston Texas 77089 —
Pioneer Research Solutions Inc. Houston Texas 77099 —
Epic Clinical Research Lewisville Texas 75057 —
North Hills Medical Research Inc. (North Hills Family Medicine) North Richland Hills Texas 76180 —
Bandera Family HealthCare Research, LLC (BFHC) San Antonio Texas 78249 —
GI Alliance - Texas Digestive Disease Consultants - San Marcos San Marcos Texas 78666 —
Texas Digestive Specialists Texas City Texas 78550 —
Advanced Research Institute - Ogden Ogden Utah 84405 —
Advanced Research Institute - Sandy Sandy City Utah 84092 —
Manassas Clinical Research Center Manassas Virginia 20110 —
Capital Digestive Center Norfolk Virginia 23502 —
Advocate Aurora Health Research Institute Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06899217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06899217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →